락토페린 (Korean Wikipedia)

Analysis of information sources in references of the Wikipedia article "락토페린" in Korean language version.

refsWebsite

Global rank Korean rank

88nih.gov

4^th place

85doi.org

2^nd place

3^rd place

21worldcat.org

5^th place

11^th place

14semanticscholar.org

11^th place

310^th place

6harvard.edu

18^th place

27^th place

3books.google.com

3^rd place

9^th place

3web.archive.org

1^st place

2ensembl.org

1,626^th place

501^st place

2sciencedirect.com

149^th place

122^nd place

2wiley.com

222^nd place

164^th place

1rupress.org

low place

1eurekalert.org

3,538^th place

1,857^th place

1actachemscand.org

low place

1archive.org

6^th place

18^th place

1agriculturejournals.cz

low place

1arccjournals.com

low place

1google.co.kr

9,121^st place

72^nd place

1jimmunol.org

low place

8,868^th place

1jbc.org

4,455^th place

1,231^st place

1karger.com

4,489^th place

3,633^rd place

1vri.cz

low place

1haematologica.org

low place

1psu.edu

207^th place

220^th place

1bmj.com

1,226^th place

829^th place

1lww.com

2,769^th place

1,748^th place

1europa.eu

68^th place

145^th place

1bioalaxia.eu

low place

1nii.ac.jp

304^th place

491^st place

1ias.ac.in

6,086^th place

7,421^st place

1degruyter.com

1,425^th place

6,905^th place

actachemscand.org

Johansson B, Virtanen AI, Tweit RC, Dodson RM (1960). “Isolation of an iron-containing red protein from human milk” (PDF). 《Acta Chem. Scand.》 14 (2): 510–512. doi:10.3891/acta.chem.scand.14-0510.

agriculturejournals.cz

L. Adlerova, A. Bartoskova, M. Faldyna (2008). “Lactoferrin: a review” (PDF). 《Veterinarni Medicina》: 457-468. CS1 관리 - 여러 이름 (링크)

arccjournals.com

Sharma, Rajan; Chakraborty*, Dibyendu; Gupta, Parul (2015년 4월 12일). “Bovine lactoferrin and its functions in animals A Review”. 《Agricultural Reviews》 (영어) 36 (4): 321–326.

archive.org

Baker HM, Anderson BF, Kidd RD, Shewry SC, Baker EN (2000). 〈Lactoferrin three-dimensional structure: a framework for interpreting function〉. Shimazaki K. 《Lactoferrin: structure, function, and applications: proceedings of the 4th International Conference on Lactoferrin: Structure, Function, and Applications, held in Sapporo, Japan, 18–22 May 1999》. Amsterdam: Elsevier. ISBN 978-0-444-50317-6.

bioalaxia.eu

“Meveol: orphan drug status granted by the FDA for the treatment of cystic fibrosis”. United States Food and Drug Administration. 2009년 11월 5일. 2009년 12월 24일에 원본 문서에서 보존된 문서. 2010년 1월 23일에 확인함.

bmj.com

fg.bmj.com

Lamb, C. A.; Mansfield, J. C. (2011년 1월 1일). “Measurement of faecal calprotectin and lactoferrin in inflammatory bowel disease”. 《Frontline Gastroenterology》 (영어) 2 (1): 13–18. doi:10.1136/fg.2010.001362. ISSN 2041-4137. PMID 23904968.

books.google.com

Levin RE, Kalidas S, Gopinadhan P, Pometto A (2006). 《Food biotechnology》. Boca Raton, FL: CRC/Taylor & Francis. 1028쪽. ISBN 978-0-8247-5329-0.
Pursel VG (1998). 〈Modification of Production Traits〉. Clark AJ. 《Animal Breeding: Technology for the 21st Century (Modern Genetics)》. Boca Raton: CRC. 191쪽. ISBN 978-90-5702-292-0.
Naidu AS (2000). 《Lactoferrin: natural, multifunctional, antimicrobial》. Boca Raton: CRC Press. 1–2쪽. ISBN 978-0-8493-0909-0.

degruyter.com

Zhang, Guomei (2013년 6월 1일). “Functional gold nanoparticles for sensing applications”. 《Nanotechnology Reviews》 (영어) 2 (3): 269–288. doi:10.1515/ntrev-2012-0088. ISSN 2191-9097.

doi.org

dx.doi.org

Masson, P. L.; Heremans, J. F.; Schonne, E. (1969년 9월 1일). “Lactoferrin, an iron-binding protein in neutrophilic leukocytes”. 《The Journal of Experimental Medicine》 130 (3): 643–658. doi:10.1084/jem.130.3.643. ISSN 0022-1007. PMC 2138704. PMID 4979954.
Sánchez L, Calvo M, Brock JH (May 1992). “Biological role of lactoferrin”. 《Archives of Disease in Childhood》 67 (5): 657–61. doi:10.1136/adc.67.5.657. PMC 1793702. PMID 1599309.
Ali AS, Hasan SS, Kow CS, Merchant HA (October 2021). “Lactoferrin reduces the risk of respiratory tract infections: A meta-analysis of randomized controlled trials”. 《Clinical Nutrition ESPEN》 45: 26–32. doi:10.1016/j.clnesp.2021.08.019. PMID 34620326. S2CID 238475090.
Groves ML (1960). “The Isolation of a Red Protein from Milk”. 《Journal of the American Chemical Society》 82 (13): 3345. doi:10.1021/ja01498a029.
Johansson B, Virtanen AI, Tweit RC, Dodson RM (1960). “Isolation of an iron-containing red protein from human milk” (PDF). 《Acta Chem. Scand.》 14 (2): 510–512. doi:10.3891/acta.chem.scand.14-0510.
Kang JF, Li XL, Zhou RY, Li LH, Feng FJ, Guo XL (June 2008). “Bioinformatics analysis of lactoferrin gene for several species”. 《Biochemical Genetics》 46 (5–6): 312–22. doi:10.1007/s10528-008-9147-9. PMID 18228129. S2CID 952135.
Seyfert HM, Tuckoricz A, Interthal H, Koczan D, Hobom G (June 1994). “Structure of the bovine lactoferrin-encoding gene and its promoter”. 《Gene》 143 (2): 265–9. doi:10.1016/0378-1119(94)90108-2. PMID 8206385.
O'Halloran F, Bahar B, Buckley F, O'Sullivan O, Sweeney T, Giblin L (January 2009). “Characterisation of single nucleotide polymorphisms identified in the bovine lactoferrin gene sequences across a range of dairy cow breeds”. 《Biochimie》 91 (1): 68–75. doi:10.1016/j.biochi.2008.05.011. PMID 18554515.
Birgens HS (April 1985). “Lactoferrin in plasma measured by an ELISA technique: evidence that plasma lactoferrin is an indicator of neutrophil turnover and bone marrow activity in acute leukaemia”. 《Scandinavian Journal of Haematology》 34 (4): 326–31. doi:10.1111/j.1600-0609.1985.tb00757.x. PMID 3858982.
Baker EN, Baker HM (November 2005). “Molecular structure, binding properties and dynamics of lactoferrin”. 《Cellular and Molecular Life Sciences》 62 (22): 2531–9. doi:10.1007/s00018-005-5368-9. PMID 16261257. S2CID 218464085.
Elzoghby, Ahmed O.; Abdelmoneem, Mona A.; Hassanin, Islam A.; Abd Elwakil, Mahmoud M.; Elnaggar, Manar A.; Mokhtar, Sarah; Fang, Jia-You; Elkhodairy, Kadria A. (2020년 12월). “Lactoferrin, a multi-functional glycoprotein: Active therapeutic, drug nanocarrier & targeting ligand”. 《Biomaterials》 263: 120355. doi:10.1016/j.biomaterials.2020.120355. ISSN 0142-9612. PMC 7480805. PMID 32932142.
Giansanti, Francesco; Panella, Gloria; Leboffe, Loris; Antonini, Giovanni (2016년 9월 27일). “Lactoferrin from Milk: Nutraceutical and Pharmacological Properties”. 《Pharmaceuticals》 9 (4): 61. doi:10.3390/ph9040061. ISSN 1424-8247. PMC 5198036. PMID 27690059.
Håkansson A, Zhivotovsky B, Orrenius S, Sabharwal H, Svanborg C (August 1995). “Apoptosis induced by a human milk protein”. 《Proceedings of the National Academy of Sciences of the United States of America》 92 (17): 8064–8. Bibcode:1995PNAS...92.8064H. doi:10.1073/pnas.92.17.8064. PMC 41287. PMID 7644538.
Jameson GB, Anderson BF, Norris GE, Thomas DH, Baker EN (November 1998). “Structure of human apolactoferrin at 2.0 A resolution. Refinement and analysis of ligand-induced conformational change”. 《Acta Crystallographica Section D》 54 (Pt 6 Pt 2): 1319–35. doi:10.1107/S0907444998004417. PMID 10089508.
Mazurier J, Spik G (May 1980). “Comparative study of the iron-binding properties of human transferrins. I. Complete and sequential iron saturation and desaturation of the lactotransferrin”. 《Biochimica et Biophysica Acta》 629 (2): 399–408. doi:10.1016/0304-4165(80)90112-9. PMID 6770907.
Shongwe MS, Smith CA, Ainscough EW, Baker HM, Brodie AM, Baker EN (May 1992). “Anion binding by human lactoferrin: results from crystallographic and physicochemical studies”. 《Biochemistry》 31 (18): 4451–8. doi:10.1021/bi00133a010. PMID 1581301.
Bagby GC, Bennett RM (July 1982). “Feedback regulation of granulopoiesis: polymerization of lactoferrin abrogates its ability to inhibit CSA production”. 《Blood》 60 (1): 108–12. doi:10.1182/blood.V60.1.108.108. PMID 6979357.
Mantel C, Miyazawa K, Broxmeyer HE (1994). 〈Physical characteristics and polymerization during iron saturation of lactoferrin, a myelopoietic regulatory molecule with suppressor activity〉. 《Lactoferrin Structure and Function》. Advances in, Experimental Medicine and Biology 357. 121–32쪽. doi:10.1007/978-1-4615-2548-6_12. ISBN 978-0-306-44734-1. PMID 7762423.
Furmanski P, Li ZP, Fortuna MB, Swamy CV, Das MR (August 1989). “Multiple molecular forms of human lactoferrin. Identification of a class of lactoferrins that possess ribonuclease activity and lack iron-binding capacity”. 《The Journal of Experimental Medicine》 170 (2): 415–29. doi:10.1084/jem.170.2.415. PMC 2189405. PMID 2754391.
Sinha, Mau; Kaushik, Sanket; Kaur, Punit; Sharma, Sujata; Singh, Tej P. (2013). “Antimicrobial Lactoferrin Peptides: The Hidden Players in the Protective Function of a Multifunctional Protein”. 《International Journal of Peptides》 2013: 390230. doi:10.1155/2013/390230. ISSN 1687-9767. PMC 3608178. PMID 23554820.
Bruni, Natascia; Capucchio, Maria Teresa; Biasibetti, Elena; Pessione, Enrica; Cirrincione, Simona; Giraudo, Leonardo; Corona, Antonio; Dosio, Franco (2016년 6월 11일). “Antimicrobial Activity of Lactoferrin-Related Peptides and Applications in Human and Veterinary Medicine”. 《Molecules》 21 (6): 752. doi:10.3390/molecules21060752. ISSN 1420-3049. PMC 6273662. PMID 27294909.
Does, Anne M. van der; Hensbergen, Paul J.; Bogaards, Sylvia J.; Cansoy, Medine; Deelder, André M.; Leeuwen, Hans C. van; Drijfhout, Jan W.; Dissel, Jaap T. van; Nibbering, Peter H. (2012년 5월 15일). “The Human Lactoferrin-Derived Peptide hLF1-11 Exerts Immunomodulatory Effects by Specific Inhibition of Myeloperoxidase Activity”. 《The Journal of Immunology》 (영어) 188 (10): 5012–5019. doi:10.4049/jimmunol.1102777. ISSN 0022-1767. PMID 22523385.
Ward, P. P.; Mendoza-Meneses, M.; Mulac-Jericevic, B.; Cunningham, G. A.; Saucedo-Cardenas, O.; Teng, C. T.; Conneely, O. M. (1999년 4월). “Restricted spatiotemporal expression of lactoferrin during murine embryonic development”. 《Endocrinology》 140 (4): 1852–1860. doi:10.1210/endo.140.4.6671. ISSN 0013-7227. PMID 10098524.
Sanchez, Lourdes; Lujan, Luis; Oria, Rosa; Castillo, Helena; Perez, Dolores; Ena, Jose Manuel; Calvo, Miguel (1992년 5월 1일). “Synthesis of Lactoferrin and Transport of Transferrin in the Lactating Mammary Gland of Sheep”. 《Journal of Dairy Science》 (영어) 75 (5): 1257–1262. doi:10.3168/jds.S0022-0302(92)77875-8. ISSN 0022-0302.
Fillebeen, C.; Descamps, L.; Dehouck, M. P.; Fenart, L.; Benaïssa, M.; Spik, G.; Cecchelli, R.; Pierce, A. (1999년 3월 12일). “Receptor-mediated transcytosis of lactoferrin through the blood-brain barrier”. 《The Journal of Biological Chemistry》 274 (11): 7011–7017. doi:10.1074/jbc.274.11.7011. ISSN 0021-9258. PMID 10066755.
Fillebeen, Carine; Dehouck, Bénédicte; Benaïssa, Monique; Dhennin-Duthille, Isabelle; Cecchelli, Roméo; Pierce, Annick (2002년 1월 18일). “Tumor Necrosis Factor-α Increases Lactoferrin Transcytosis Through the Blood-Brain Barrier”. 《Journal of Neurochemistry》 (영어) 73 (6): 2491–2500. doi:10.1046/j.1471-4159.1999.0732491.x.
Donovan, Sharon M. (2019). “Human Milk Proteins: Composition and Physiological Significance”. 《Human Milk: Composition, Clinical Benefits and Future Opportunities》 (영어) 90: 93–101. doi:10.1159/000490298. PMID 30865978.
Teng, Christina T. (2002). “Lactoferrin gene expression and regulation: an overview”. 《Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire》 80 (1): 7–16. doi:10.1139/o01-215. ISSN 0829-8211. PMID 11908645.
Adlerova L, Bartoskova A, Faldyna M (2008). “Lactoferrin: a review” (PDF). 《Veterinarni Medicina》 53 (9): 457. doi:10.17221/1978-VETMED. 2020년 1월 9일에 원본 문서 (PDF)에서 보존된 문서. 2022년 7월 16일에 확인함.
Farnaud S, Evans RW (November 2003). “Lactoferrin--a multifunctional protein with antimicrobial properties”. 《Molecular Immunology》 40 (7): 395–405. doi:10.1016/S0161-5890(03)00152-4. PMID 14568385.
Xanthou M (1998). “Immune protection of human milk”. 《Biology of the Neonate》 74 (2): 121–33. doi:10.1159/000014018. PMID 9691154. S2CID 46828227.
Odell EW, Sarra R, Foxworthy M, Chapple DS, Evans RW (March 1996). “Antibacterial activity of peptides homologous to a loop region in human lactoferrin”. 《FEBS Letters》 382 (1–2): 175–8. doi:10.1016/0014-5793(96)00168-8. PMID 8612745. S2CID 30937106.
Kuwata H, Yip TT, Yip CL, Tomita M, Hutchens TW (April 1998). “Bactericidal domain of lactoferrin: detection, quantitation, and characterization of lactoferricin in serum by SELDI affinity mass spectrometry”. 《Biochemical and Biophysical Research Communications》 245 (3): 764–73. doi:10.1006/bbrc.1998.8466. PMID 9588189.
Sojar HT, Hamada N, Genco RJ (January 1998). “Structures involved in the interaction of Porphyromonas gingivalis fimbriae and human lactoferrin”. 《FEBS Letters》 422 (2): 205–8. doi:10.1016/S0014-5793(98)00002-7. PMID 9490007. S2CID 25875928.
Andrés MT, Fierro JF (October 2010). “Antimicrobial mechanism of action of transferrins: selective inhibition of H+-ATPase”. 《Antimicrobial Agents and Chemotherapy》 54 (10): 4335–42. doi:10.1128/AAC.01620-09. PMC 2944611. PMID 20625147.
van der Strate BW, Beljaars L, Molema G, Harmsen MC, Meijer DK (December 2001). “Antiviral activities of lactoferrin”. 《Antiviral Research》 52 (3): 225–239. CiteSeerX 10.1.1.104.745. doi:10.1016/S0166-3542(01)00195-4. PMID 11675140.
Fujihara T, Hayashi K (1995). “Lactoferrin inhibits herpes simplex virus type-1 (HSV-1) infection to mouse cornea”. 《Archives of Virology》 140 (8): 1469–1472. doi:10.1007/BF01322673. PMID 7661698. S2CID 4396295.
Giansanti F, Rossi P, Massucci MT, Botti D, Antonini G, Valenti P, Seganti L (2002). “Antiviral activity of ovotransferrin discloses an evolutionary strategy for the defensive activities of lactoferrin”. 《Biochemistry and Cell Biology = Biochimie et Biologie Cellulaire》 80 (1): 125–130. doi:10.1139/o01-208. PMID 11908636.
Krzyzowska M, Chodkowski M, Janicka M, Dmowska D, Tomaszewska E, Ranoszek-Soliwoda K, 외. (January 2022). “Lactoferrin-Functionalized Noble Metal Nanoparticles as New Antivirals for HSV-2 Infection”. 《Microorganisms》 10 (1): 110. doi:10.3390/microorganisms10010110. PMC 8780146. PMID 35056558.
Harmsen MC, Swart PJ, de Béthune MP, Pauwels R, De Clercq E, The TH, Meijer DK (August 1995). “Antiviral effects of plasma and milk proteins: lactoferrin shows potent activity against both human immunodeficiency virus and human cytomegalovirus replication in vitro”. 《The Journal of Infectious Diseases》 172 (2): 380–388. doi:10.1093/infdis/172.2.380. PMID 7622881.
Puddu P, Borghi P, Gessani S, Valenti P, Belardelli F, Seganti L (September 1998). “Antiviral effect of bovine lactoferrin saturated with metal ions on early steps of human immunodeficiency virus type 1 infection”. 《The International Journal of Biochemistry & Cell Biology》 30 (9): 1055–1062. doi:10.1016/S1357-2725(98)00066-1. PMID 9785469.
Azzam HS, Goertz C, Fritts M, Jonas WB (February 2007). “Natural products and chronic hepatitis C virus”. 《Liver International》 27 (1): 17–25. doi:10.1111/j.1478-3231.2006.01408.x. PMID 17241377. S2CID 7732075.
Nozaki A, Ikeda M, Naganuma A, Nakamura T, Inudoh M, Tanaka K, Kato N (March 2003). “Identification of a lactoferrin-derived peptide possessing binding activity to hepatitis C virus E2 envelope protein”. 《The Journal of Biological Chemistry》 278 (12): 10162–10173. doi:10.1074/jbc.M207879200. PMID 12522210.
Arnold D, Di Biase AM, Marchetti M, Pietrantoni A, Valenti P, Seganti L, Superti F (February 2002). “Antiadenovirus activity of milk proteins: lactoferrin prevents viral infection”. 《Antiviral Research》 53 (2): 153–158. doi:10.1016/S0166-3542(01)00197-8. PMID 11750941.
Carvalho CA, Sousa IP, Silva JL, Oliveira AC, Gonçalves RB, Gomes AM (March 2014). “Inhibition of Mayaro virus infection by bovine lactoferrin”. 《Virology》. 452-453: 297–302. doi:10.1016/j.virol.2014.01.022. PMID 24606707.
Chang R, Ng TB, Sun WZ (September 2020). “Lactoferrin as potential preventative and adjunct treatment for COVID-19”. 《International Journal of Antimicrobial Agents》 56 (3): 106118. doi:10.1016/j.ijantimicag.2020.106118. PMC 7390755. PMID 32738305.
Wang Y, Wang P, Wang H, Luo Y, Wan L, Jiang M, Chu Y (December 2020). “Lactoferrin for the treatment of COVID-19 (Review)”. 《Experimental and Therapeutic Medicine》 20 (6): 272. doi:10.3892/etm.2020.9402. PMC 7664603. PMID 33199997.
Mirabelli C, Wotring JW, Zhang CJ, McCarty SM, Fursmidt R, Pretto CD, 외. (September 2021). “Morphological cell profiling of SARS-CoV-2 infection identifies drug repurposing candidates for COVID-19”. 《Proceedings of the National Academy of Sciences of the United States of America》 118 (36). doi:10.1073/pnas.2105815118. PMC 8433531. PMID 34413211.
Rosa L, Tripepi G, Naldi E, Aimati M, Santangeli S, Venditto F, 외. (September 2021). “Ambulatory COVID-19 Patients Treated with Lactoferrin as a Supplementary Antiviral Agent: A Preliminary Study”. 《Journal of Clinical Medicine》 10 (18): 4276. doi:10.3390/jcm10184276. PMC 8469309. PMID 34575388.
Reghunathan R, Jayapal M, Hsu LY, Chng HH, Tai D, Leung BP, Melendez AJ (January 2005). “Expression profile of immune response genes in patients with Severe Acute Respiratory Syndrome”. 《BMC Immunology》 6: 2. doi:10.1186/1471-2172-6-2. PMC 546205. PMID 15655079.
Wakabayashi H, Uchida K, Yamauchi K, Teraguchi S, Hayasawa H, Yamaguchi H (October 2000). “Lactoferrin given in food facilitates dermatophytosis cure in guinea pig models”. 《The Journal of Antimicrobial Chemotherapy》 46 (4): 595–602. doi:10.1093/jac/46.4.595. PMID 11020258.
Lupetti A, Paulusma-Annema A, Welling MM, Dogterom-Ballering H, Brouwer CP, Senesi S, Van Dissel JT, Nibbering PH (January 2003). “Synergistic activity of the N-terminal peptide of human lactoferrin and fluconazole against Candida species”. 《Antimicrobial Agents and Chemotherapy》 47 (1): 262–7. doi:10.1128/AAC.47.1.262-267.2003. PMC 149030. PMID 12499200.
Viejo-Díaz M, Andrés MT, Fierro JF (April 2004). “Modulation of in vitro fungicidal activity of human lactoferrin against Candida albicans by extracellular cation concentration and target cell metabolic activity”. 《Antimicrobial Agents and Chemotherapy》 48 (4): 1242–8. doi:10.1128/AAC.48.4.1242-1248.2004. PMC 375254. PMID 15047526.
Takakura N, Wakabayashi H, Ishibashi H, Teraguchi S, Tamura Y, Yamaguchi H, Abe S (August 2003). “Oral lactoferrin treatment of experimental oral candidiasis in mice”. 《Antimicrobial Agents and Chemotherapy》 47 (8): 2619–23. doi:10.1128/AAC.47.8.2619-2623.2003. PMC 166093. PMID 12878528.
Masci JR (October 2000). “Complete response of severe, refractory oral candidiasis to mouthwash containing lactoferrin and lysozyme”. 《AIDS》 14 (15): 2403–4. doi:10.1097/00002030-200010200-00023. PMID 11089630.
Kuipers ME, de Vries HG, Eikelboom MC, Meijer DK, Swart PJ (November 1999). “Synergistic fungistatic effects of lactoferrin in combination with antifungal drugs against clinical Candida isolates”. 《Antimicrobial Agents and Chemotherapy》 43 (11): 2635–41. doi:10.1128/AAC.43.11.2635. PMC 89536. PMID 10543740.
Andrés MT, Viejo-Díaz M, Fierro JF (November 2008). “Human lactoferrin induces apoptosis-like cell death in Candida albicans: critical role of K+-channel-mediated K+ efflux”. 《Antimicrobial Agents and Chemotherapy》 52 (11): 4081–8. doi:10.1128/AAC.01597-07. PMC 2573133. PMID 18710913.
Tsuda H, Sekine K, Fujita K, Ligo M (2002). “Cancer prevention by bovine lactoferrin and underlying mechanisms--a review of experimental and clinical studies”. 《Biochemistry and Cell Biology》 80 (1): 131–6. doi:10.1139/o01-239. PMID 11908637.
Chandra Mohan KV, Kumaraguruparan R, Prathiba D, Nagini S (September 2006). “Modulation of xenobiotic-metabolizing enzymes and redox status during chemoprevention of hamster buccal carcinogenesis by bovine lactoferrin”. 《Nutrition》 22 (9): 940–6. doi:10.1016/j.nut.2006.05.017. PMID 16928475.
McCormick JJ, Larson LJ, Rich MA (October 1974). “RNase inhibition of reverse transcriptase activity in human milk”. 《Nature》 251 (5477): 737–40. Bibcode:1974Natur.251..737M. doi:10.1038/251737a0. PMID 4139659. S2CID 4160337.
Das MR, Padhy LC, Koshy R, Sirsat SM, Rich MA (August 1976). “Human milk samples from different ethnic groups contain RNase that inhibits, and plasma membrane that stimulates, reverse transcription”. 《Nature》 262 (5571): 802–5. Bibcode:1976Natur.262..802D. doi:10.1038/262802a0. PMID 60710. S2CID 4216981.
Liao Y, Lopez V, Shafizadeh TB, Halsted CH, Lönnerdal B (November 2007). “Cloning of a pig homologue of the human lactoferrin receptor: expression and localization during intestinal maturation in piglets”. 《Comparative Biochemistry and Physiology. Part A, Molecular & Integrative Physiology》 148 (3): 584–90. doi:10.1016/j.cbpa.2007.08.001. PMC 2265088. PMID 17766154.
Rawat P, Kumar S, Sheokand N, Raje CI, Raje M (June 2012). “The multifunctional glycolytic protein glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is a novel macrophage lactoferrin receptor”. 《Biochemistry and Cell Biology》 90 (3): 329–38. doi:10.1139/o11-058. PMID 22292499.
Bharadwaj S, Naidu AG, Betageri GV, Prasadarao NV, Naidu AS (September 2009). “Milk ribonuclease-enriched lactoferrin induces positive effects on bone turnover markers in postmenopausal women”. 《Osteoporosis International》 20 (9): 1603–11. doi:10.1007/s00198-009-0839-8. PMID 19172341. S2CID 10711802.
Bharadwaj S, Naidu TA, Betageri GV, Prasadarao NV, Naidu AS (November 2010). “Inflammatory responses improve with milk ribonuclease-enriched lactoferrin supplementation in postmenopausal women”. 《Inflammation Research》 59 (11): 971–8. doi:10.1007/s00011-010-0211-7. PMID 20473630. S2CID 3180066.
Guo, Hui Yuan; Jiang, Lu; Ibrahim, Salam A.; Zhang, Lian; Zhang, Hao; Zhang, Ming; Ren, Fa Zheng (2009년 5월). “Orally administered lactoferrin preserves bone mass and microarchitecture in ovariectomized rats”. 《The Journal of Nutrition》 139 (5): 958–964. doi:10.3945/jn.108.100586. ISSN 1541-6100. PMID 19321577.
Rosenmund A, Kuyas C, Haeberli A (November 1986). “Oxidative radioiodination damage to human lactoferrin”. 《The Biochemical Journal》 240 (1): 239–45. doi:10.1042/bj2400239. PMC 1147399. PMID 3827843.
Ohashi Y, Ishida R, Kojima T, Goto E, Matsumoto Y, Watanabe K, Ishida N, Nakata K, Takeuchi T, Tsubota K (August 2003). “Abnormal protein profiles in tears with dry eye syndrome”. 《American Journal of Ophthalmology》 136 (2): 291–9. doi:10.1016/S0002-9394(03)00203-4. PMID 12888052.
Karns K, Herr AE (November 2011). “Human tear protein analysis enabled by an alkaline microfluidic homogeneous immunoassay”. 《Analytical Chemistry》 83 (21): 8115–22. doi:10.1021/ac202061v. PMID 21910436.
Lamb, C. A.; Mansfield, J. C. (2011년 1월 1일). “Measurement of faecal calprotectin and lactoferrin in inflammatory bowel disease”. 《Frontline Gastroenterology》 (영어) 2 (1): 13–18. doi:10.1136/fg.2010.001362. ISSN 2041-4137. PMID 23904968.
Kane, Sunanda V.; Sandborn, William J.; Rufo, Paul A.; Zholudev, Anna; Boone, James; Lyerly, David; Camilleri, Michael; Hanauer, Stephen B. (2003). “Fecal lactoferrin is a sensitive and specific marker in identifying intestinal inflammation”. 《The American Journal of Gastroenterology》 98 (6): 1309–1314. doi:10.1111/j.1572-0241.2003.07458.x. ISSN 0002-9270. PMID 12818275.
Walker, Thomas R.; Land, Michelle L.; Kartashov, Alex; Saslowsky, Tracee M.; Lyerly, David M.; Boone, James H.; Rufo, Paul A. (2007년 4월). “Fecal Lactoferrin Is a Sensitive and Specific Marker of Disease Activity in Children and Young Adults With Inflammatory Bowel Disease”. 《Journal of Pediatric Gastroenterology and Nutrition》 (미국 영어) 44 (4): 414–422. doi:10.1097/MPG.0b013e3180308d8e. ISSN 0277-2116.
Zhou, Xing-lu; Xu, Wen; Tang, Xiao-xiao; Luo, Lai-sheng; Tu, Jiang-feng; Zhang, Chen-jing; Xu, Xiang; Wu, Qin-dong; Pan, Wen-sheng (2014년 7월 7일). “Fecal lactoferrin in discriminating inflammatory bowel disease from Irritable bowel syndrome: a diagnostic meta-analysis”. 《BMC Gastroenterology》 14 (1): 121. doi:10.1186/1471-230X-14-121. ISSN 1471-230X. PMC 4105129. PMID 25002150. CS1 관리 - PMC 형식 (링크)
Moskwa P, Lorentzen D, Excoffon KJ, Zabner J, McCray PB, Nauseef WM, Dupuy C, Bánfi B (January 2007). “A novel host defense system of airways is defective in cystic fibrosis”. 《American Journal of Respiratory and Critical Care Medicine》 175 (2): 174–83. doi:10.1164/rccm.200607-1029OC. PMC 2720149. PMID 17082494.
Singh PK, Schaefer AL, Parsek MR, Moninger TO, Welsh MJ, Greenberg EP (October 2000). “Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms”. 《Nature》 407 (6805): 762–4. Bibcode:2000Natur.407..762S. doi:10.1038/35037627. PMID 11048725. S2CID 4372096.
Singh PK, Parsek MR, Greenberg EP, Welsh MJ (May 2002). “A component of innate immunity prevents bacterial biofilm development”. 《Nature》 417 (6888): 552–5. Bibcode:2002Natur.417..552S. doi:10.1038/417552a. PMID 12037568. S2CID 4423528.
Rogan MP, Taggart CC, Greene CM, Murphy PG, O'Neill SJ, McElvaney NG (October 2004). “Loss of microbicidal activity and increased formation of biofilm due to decreased lactoferrin activity in patients with cystic fibrosis”. 《The Journal of Infectious Diseases》 190 (7): 1245–53. doi:10.1086/423821. PMID 15346334.
Andrés MT, Viejo-Diaz M, Pérez F, Fierro JF (April 2005). “Antibiotic tolerance induced by lactoferrin in clinical Pseudomonas aeruginosa isolates from cystic fibrosis patients”. 《Antimicrobial Agents and Chemotherapy》 49 (4): 1613–6. doi:10.1128/aac.49.4.1613-1616.2005. PMC 1068597. PMID 15793153.
Rogan MP, Geraghty P, Greene CM, O'Neill SJ, Taggart CC, McElvaney NG (February 2006). “Antimicrobial proteins and polypeptides in pulmonary innate defence”. 《Respiratory Research》 7 (1): 29. doi:10.1186/1465-9921-7-29. PMC 1386663. PMID 16503962.
Manzoni, Paolo; Meyer, Michael; Stolfi, Ilaria; Rinaldi, Matteo; Cattani, Silvia; Pugni, Lorenza; Romeo, Mario Giovanni; Messner, Hubert; Decembrino, Lidia (2014년 3월 1일). “Bovine lactoferrin supplementation for prevention of necrotizing enterocolitis in very-low-birth-weight neonates: a randomized clinical trial”. 《Early Human Development》 (영어) 90: S60–S65. doi:10.1016/S0378-3782(14)70020-9. ISSN 0378-3782.
Pammi M, Suresh G (March 2020). “Enteral lactoferrin supplementation for prevention of sepsis and necrotizing enterocolitis in preterm infants”. 《The Cochrane Database of Systematic Reviews》 3: CD007137. doi:10.1002/14651858.CD007137.pub6. PMC 7106972. PMID 32232984.
Cui, Shixiu; Lv, Xueqin; Sun, Guoyun; Wu, Wenyang; Xu, Hong; Li, Yuelong; Liu, Yanfeng; Li, Jianghua; Du, Guocheng (2022년 3월). “Recent advances and prospects in purification and heterologous expression of lactoferrin”. 《Food Bioengineering》 (영어) 1 (1): 58–67. doi:10.1002/fbe2.12003. ISSN 2770-2081.
Xavier PL, Chaudhari K, Verma PK, Pal SK, Pradeep T (December 2010). “Luminescent quantum clusters of gold in transferrin family protein, lactoferrin exhibiting FRET” (PDF). 《Nanoscale》 2 (12): 2769–76. Bibcode:2010Nanos...2.2769X. doi:10.1039/C0NR00377H. PMID 20882247.
Zhang, Guomei (2013년 6월 1일). “Functional gold nanoparticles for sensing applications”. 《Nanotechnology Reviews》 (영어) 2 (3): 269–288. doi:10.1515/ntrev-2012-0088. ISSN 2191-9097.

doi.org

Zhou, Xing-lu; Xu, Wen; Tang, Xiao-xiao; Luo, Lai-sheng; Tu, Jiang-feng; Zhang, Chen-jing; Xu, Xiang; Wu, Qin-dong; Pan, Wen-sheng (2014년 7월 7일). “Fecal lactoferrin in discriminating inflammatory bowel disease from Irritable bowel syndrome: a diagnostic meta-analysis”. 《BMC Gastroenterology》 14 (1): 121. doi:10.1186/1471-230X-14-121. ISSN 1471-230X. PMC 4105129. PMID 25002150. CS1 관리 - PMC 형식 (링크)

ensembl.org

May2017.archive.ensembl.org

GRCh38: Ensembl release 89: ENSG00000012223 - 앙상블, May 2017
GRCm38: Ensembl release 89: ENSMUSG00000032496 - 앙상블, May 2017

eurekalert.org

“Lactoferrin supplements could aid in the recovery of COVID19 & other Respiratory Tract Infections”. 《EurekAlert!》 (영어). 2022년 2월 18일에 확인함. However, Dr Merchant argues that lots of low cost lactoferrin supplements being sold online are not of desired quality because with it being a biomolecule that is classed as a nutritional supplement, the production of lactoferrin isn’t legally enforced to follow the same strict regulatory process as for medicines.

europa.eu

ema.europa.eu

“Public summary of positive opinion for orphan designation of hypothiocyanite/lactoferrin for the treatment of cystic fibrosis” (PDF). 《Pre-authorisation Evaluation of Medicines for Human Use》. European Medicines Agency. 2009년 9월 7일. 2010년 5월 30일에 원본 문서 (PDF)에서 보존된 문서. 2010년 1월 23일에 확인함.

google.co.kr

books.google.co.kr

Vílchez, Juan Antonio; Albaladejo-Otón, María Dolores (2017년 9월 29일). 《New Trends in Biomarkers and Diseases: An Overview》 (영어). Bentham Science Publishers. 102-103쪽. ISBN 978-1-68108-495-4.

haematologica.org

Levay PF, Viljoen M (January 1995). “Lactoferrin: a general review” (PDF). 《Haematologica》 80 (3): 252–67. PMID 7672721.

harvard.edu

adsabs.harvard.edu

Håkansson A, Zhivotovsky B, Orrenius S, Sabharwal H, Svanborg C (August 1995). “Apoptosis induced by a human milk protein”. 《Proceedings of the National Academy of Sciences of the United States of America》 92 (17): 8064–8. Bibcode:1995PNAS...92.8064H. doi:10.1073/pnas.92.17.8064. PMC 41287. PMID 7644538.
McCormick JJ, Larson LJ, Rich MA (October 1974). “RNase inhibition of reverse transcriptase activity in human milk”. 《Nature》 251 (5477): 737–40. Bibcode:1974Natur.251..737M. doi:10.1038/251737a0. PMID 4139659. S2CID 4160337.
Das MR, Padhy LC, Koshy R, Sirsat SM, Rich MA (August 1976). “Human milk samples from different ethnic groups contain RNase that inhibits, and plasma membrane that stimulates, reverse transcription”. 《Nature》 262 (5571): 802–5. Bibcode:1976Natur.262..802D. doi:10.1038/262802a0. PMID 60710. S2CID 4216981.
Singh PK, Schaefer AL, Parsek MR, Moninger TO, Welsh MJ, Greenberg EP (October 2000). “Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms”. 《Nature》 407 (6805): 762–4. Bibcode:2000Natur.407..762S. doi:10.1038/35037627. PMID 11048725. S2CID 4372096.
Singh PK, Parsek MR, Greenberg EP, Welsh MJ (May 2002). “A component of innate immunity prevents bacterial biofilm development”. 《Nature》 417 (6888): 552–5. Bibcode:2002Natur.417..552S. doi:10.1038/417552a. PMID 12037568. S2CID 4423528.
Xavier PL, Chaudhari K, Verma PK, Pal SK, Pradeep T (December 2010). “Luminescent quantum clusters of gold in transferrin family protein, lactoferrin exhibiting FRET” (PDF). 《Nanoscale》 2 (12): 2769–76. Bibcode:2010Nanos...2.2769X. doi:10.1039/C0NR00377H. PMID 20882247.

ias.ac.in

repository.ias.ac.in

Xavier PL, Chaudhari K, Verma PK, Pal SK, Pradeep T (December 2010). “Luminescent quantum clusters of gold in transferrin family protein, lactoferrin exhibiting FRET” (PDF). 《Nanoscale》 2 (12): 2769–76. Bibcode:2010Nanos...2.2769X. doi:10.1039/C0NR00377H. PMID 20882247.

jbc.org

Fillebeen, C.; Descamps, L.; Dehouck, M. P.; Fenart, L.; Benaïssa, M.; Spik, G.; Cecchelli, R.; Pierce, A. (1999년 3월 12일). “Receptor-mediated transcytosis of lactoferrin through the blood-brain barrier”. 《The Journal of Biological Chemistry》 274 (11): 7011–7017. doi:10.1074/jbc.274.11.7011. ISSN 0021-9258. PMID 10066755.

jimmunol.org

Does, Anne M. van der; Hensbergen, Paul J.; Bogaards, Sylvia J.; Cansoy, Medine; Deelder, André M.; Leeuwen, Hans C. van; Drijfhout, Jan W.; Dissel, Jaap T. van; Nibbering, Peter H. (2012년 5월 15일). “The Human Lactoferrin-Derived Peptide hLF1-11 Exerts Immunomodulatory Effects by Specific Inhibition of Myeloperoxidase Activity”. 《The Journal of Immunology》 (영어) 188 (10): 5012–5019. doi:10.4049/jimmunol.1102777. ISSN 0022-1767. PMID 22523385.

karger.com

Donovan, Sharon M. (2019). “Human Milk Proteins: Composition and Physiological Significance”. 《Human Milk: Composition, Clinical Benefits and Future Opportunities》 (영어) 90: 93–101. doi:10.1159/000490298. PMID 30865978.

lww.com

journals.lww.com

Walker, Thomas R.; Land, Michelle L.; Kartashov, Alex; Saslowsky, Tracee M.; Lyerly, David M.; Boone, James H.; Rufo, Paul A. (2007년 4월). “Fecal Lactoferrin Is a Sensitive and Specific Marker of Disease Activity in Children and Young Adults With Inflammatory Bowel Disease”. 《Journal of Pediatric Gastroenterology and Nutrition》 (미국 영어) 44 (4): 414–422. doi:10.1097/MPG.0b013e3180308d8e. ISSN 0277-2116.

nih.gov

ncbi.nlm.nih.gov

“Human PubMed Reference:”. 《National Center for Biotechnology Information, U.S. National Library of Medicine》.
“Mouse PubMed Reference:”. 《National Center for Biotechnology Information, U.S. National Library of Medicine》.
Masson, P. L.; Heremans, J. F.; Schonne, E. (1969년 9월 1일). “Lactoferrin, an iron-binding protein in neutrophilic leukocytes”. 《The Journal of Experimental Medicine》 130 (3): 643–658. doi:10.1084/jem.130.3.643. ISSN 0022-1007. PMC 2138704. PMID 4979954.
Sánchez L, Calvo M, Brock JH (May 1992). “Biological role of lactoferrin”. 《Archives of Disease in Childhood》 67 (5): 657–61. doi:10.1136/adc.67.5.657. PMC 1793702. PMID 1599309.
Ali AS, Hasan SS, Kow CS, Merchant HA (October 2021). “Lactoferrin reduces the risk of respiratory tract infections: A meta-analysis of randomized controlled trials”. 《Clinical Nutrition ESPEN》 45: 26–32. doi:10.1016/j.clnesp.2021.08.019. PMID 34620326. S2CID 238475090.
Kang JF, Li XL, Zhou RY, Li LH, Feng FJ, Guo XL (June 2008). “Bioinformatics analysis of lactoferrin gene for several species”. 《Biochemical Genetics》 46 (5–6): 312–22. doi:10.1007/s10528-008-9147-9. PMID 18228129. S2CID 952135.
Seyfert HM, Tuckoricz A, Interthal H, Koczan D, Hobom G (June 1994). “Structure of the bovine lactoferrin-encoding gene and its promoter”. 《Gene》 143 (2): 265–9. doi:10.1016/0378-1119(94)90108-2. PMID 8206385.
O'Halloran F, Bahar B, Buckley F, O'Sullivan O, Sweeney T, Giblin L (January 2009). “Characterisation of single nucleotide polymorphisms identified in the bovine lactoferrin gene sequences across a range of dairy cow breeds”. 《Biochimie》 91 (1): 68–75. doi:10.1016/j.biochi.2008.05.011. PMID 18554515.
Birgens HS (April 1985). “Lactoferrin in plasma measured by an ELISA technique: evidence that plasma lactoferrin is an indicator of neutrophil turnover and bone marrow activity in acute leukaemia”. 《Scandinavian Journal of Haematology》 34 (4): 326–31. doi:10.1111/j.1600-0609.1985.tb00757.x. PMID 3858982.
Baker EN, Baker HM (November 2005). “Molecular structure, binding properties and dynamics of lactoferrin”. 《Cellular and Molecular Life Sciences》 62 (22): 2531–9. doi:10.1007/s00018-005-5368-9. PMID 16261257. S2CID 218464085.
Elzoghby, Ahmed O.; Abdelmoneem, Mona A.; Hassanin, Islam A.; Abd Elwakil, Mahmoud M.; Elnaggar, Manar A.; Mokhtar, Sarah; Fang, Jia-You; Elkhodairy, Kadria A. (2020년 12월). “Lactoferrin, a multi-functional glycoprotein: Active therapeutic, drug nanocarrier & targeting ligand”. 《Biomaterials》 263: 120355. doi:10.1016/j.biomaterials.2020.120355. ISSN 0142-9612. PMC 7480805. PMID 32932142.
Giansanti, Francesco; Panella, Gloria; Leboffe, Loris; Antonini, Giovanni (2016년 9월 27일). “Lactoferrin from Milk: Nutraceutical and Pharmacological Properties”. 《Pharmaceuticals》 9 (4): 61. doi:10.3390/ph9040061. ISSN 1424-8247. PMC 5198036. PMID 27690059.
Håkansson A, Zhivotovsky B, Orrenius S, Sabharwal H, Svanborg C (August 1995). “Apoptosis induced by a human milk protein”. 《Proceedings of the National Academy of Sciences of the United States of America》 92 (17): 8064–8. Bibcode:1995PNAS...92.8064H. doi:10.1073/pnas.92.17.8064. PMC 41287. PMID 7644538.
Jameson GB, Anderson BF, Norris GE, Thomas DH, Baker EN (November 1998). “Structure of human apolactoferrin at 2.0 A resolution. Refinement and analysis of ligand-induced conformational change”. 《Acta Crystallographica Section D》 54 (Pt 6 Pt 2): 1319–35. doi:10.1107/S0907444998004417. PMID 10089508.
Levay PF, Viljoen M (1995). “Lactoferrin: a general review”. 《Haematologica》 80 (3): 252–67. PMID 7672721.
Mazurier J, Spik G (May 1980). “Comparative study of the iron-binding properties of human transferrins. I. Complete and sequential iron saturation and desaturation of the lactotransferrin”. 《Biochimica et Biophysica Acta》 629 (2): 399–408. doi:10.1016/0304-4165(80)90112-9. PMID 6770907.
Shongwe MS, Smith CA, Ainscough EW, Baker HM, Brodie AM, Baker EN (May 1992). “Anion binding by human lactoferrin: results from crystallographic and physicochemical studies”. 《Biochemistry》 31 (18): 4451–8. doi:10.1021/bi00133a010. PMID 1581301.
Bennett RM, Davis J (January 1982). “Lactoferrin interacts with deoxyribonucleic acid: a preferential reactivity with double-stranded DNA and dissociation of DNA-anti-DNA complexes”. 《The Journal of Laboratory and Clinical Medicine》 99 (1): 127–38. PMID 6274982.
Bagby GC, Bennett RM (July 1982). “Feedback regulation of granulopoiesis: polymerization of lactoferrin abrogates its ability to inhibit CSA production”. 《Blood》 60 (1): 108–12. doi:10.1182/blood.V60.1.108.108. PMID 6979357.
Mantel C, Miyazawa K, Broxmeyer HE (1994). 〈Physical characteristics and polymerization during iron saturation of lactoferrin, a myelopoietic regulatory molecule with suppressor activity〉. 《Lactoferrin Structure and Function》. Advances in, Experimental Medicine and Biology 357. 121–32쪽. doi:10.1007/978-1-4615-2548-6_12. ISBN 978-0-306-44734-1. PMID 7762423.
Furmanski P, Li ZP, Fortuna MB, Swamy CV, Das MR (August 1989). “Multiple molecular forms of human lactoferrin. Identification of a class of lactoferrins that possess ribonuclease activity and lack iron-binding capacity”. 《The Journal of Experimental Medicine》 170 (2): 415–29. doi:10.1084/jem.170.2.415. PMC 2189405. PMID 2754391.
Sinha, Mau; Kaushik, Sanket; Kaur, Punit; Sharma, Sujata; Singh, Tej P. (2013). “Antimicrobial Lactoferrin Peptides: The Hidden Players in the Protective Function of a Multifunctional Protein”. 《International Journal of Peptides》 2013: 390230. doi:10.1155/2013/390230. ISSN 1687-9767. PMC 3608178. PMID 23554820.
Bruni, Natascia; Capucchio, Maria Teresa; Biasibetti, Elena; Pessione, Enrica; Cirrincione, Simona; Giraudo, Leonardo; Corona, Antonio; Dosio, Franco (2016년 6월 11일). “Antimicrobial Activity of Lactoferrin-Related Peptides and Applications in Human and Veterinary Medicine”. 《Molecules》 21 (6): 752. doi:10.3390/molecules21060752. ISSN 1420-3049. PMC 6273662. PMID 27294909.
Does, Anne M. van der; Hensbergen, Paul J.; Bogaards, Sylvia J.; Cansoy, Medine; Deelder, André M.; Leeuwen, Hans C. van; Drijfhout, Jan W.; Dissel, Jaap T. van; Nibbering, Peter H. (2012년 5월 15일). “The Human Lactoferrin-Derived Peptide hLF1-11 Exerts Immunomodulatory Effects by Specific Inhibition of Myeloperoxidase Activity”. 《The Journal of Immunology》 (영어) 188 (10): 5012–5019. doi:10.4049/jimmunol.1102777. ISSN 0022-1767. PMID 22523385.
Ward, P. P.; Mendoza-Meneses, M.; Mulac-Jericevic, B.; Cunningham, G. A.; Saucedo-Cardenas, O.; Teng, C. T.; Conneely, O. M. (1999년 4월). “Restricted spatiotemporal expression of lactoferrin during murine embryonic development”. 《Endocrinology》 140 (4): 1852–1860. doi:10.1210/endo.140.4.6671. ISSN 0013-7227. PMID 10098524.
Iyer, S.; Lönnerdal, B. (1993년 4월). “Lactoferrin, lactoferrin receptors and iron metabolism”. 《European Journal of Clinical Nutrition》 47 (4): 232–241. ISSN 0954-3007. PMID 8491159.
Fillebeen, C.; Descamps, L.; Dehouck, M. P.; Fenart, L.; Benaïssa, M.; Spik, G.; Cecchelli, R.; Pierce, A. (1999년 3월 12일). “Receptor-mediated transcytosis of lactoferrin through the blood-brain barrier”. 《The Journal of Biological Chemistry》 274 (11): 7011–7017. doi:10.1074/jbc.274.11.7011. ISSN 0021-9258. PMID 10066755.
Donovan, Sharon M. (2019). “Human Milk Proteins: Composition and Physiological Significance”. 《Human Milk: Composition, Clinical Benefits and Future Opportunities》 (영어) 90: 93–101. doi:10.1159/000490298. PMID 30865978.
Teng, Christina T. (2002). “Lactoferrin gene expression and regulation: an overview”. 《Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire》 80 (1): 7–16. doi:10.1139/o01-215. ISSN 0829-8211. PMID 11908645.
Berlutti, Francesca; Pilloni, Andrea; Pietropaoli, Miriam; Polimeni, Antonella; Valenti, Piera (2012년 1월 27일). “Lactoferrin and oral diseases: current status and perspective in periodontitis”. 《Annali di Stomatologia》 2 (3-4): 10–18. ISSN 1824-0852. PMC 3314318. PMID 22545184.
Levay PF, Viljoen M (January 1995). “Lactoferrin: a general review” (PDF). 《Haematologica》 80 (3): 252–67. PMID 7672721.
Farnaud S, Evans RW (November 2003). “Lactoferrin--a multifunctional protein with antimicrobial properties”. 《Molecular Immunology》 40 (7): 395–405. doi:10.1016/S0161-5890(03)00152-4. PMID 14568385.
Xanthou M (1998). “Immune protection of human milk”. 《Biology of the Neonate》 74 (2): 121–33. doi:10.1159/000014018. PMID 9691154. S2CID 46828227.
Odell EW, Sarra R, Foxworthy M, Chapple DS, Evans RW (March 1996). “Antibacterial activity of peptides homologous to a loop region in human lactoferrin”. 《FEBS Letters》 382 (1–2): 175–8. doi:10.1016/0014-5793(96)00168-8. PMID 8612745. S2CID 30937106.
Kuwata H, Yip TT, Yip CL, Tomita M, Hutchens TW (April 1998). “Bactericidal domain of lactoferrin: detection, quantitation, and characterization of lactoferricin in serum by SELDI affinity mass spectrometry”. 《Biochemical and Biophysical Research Communications》 245 (3): 764–73. doi:10.1006/bbrc.1998.8466. PMID 9588189.
Sojar HT, Hamada N, Genco RJ (January 1998). “Structures involved in the interaction of Porphyromonas gingivalis fimbriae and human lactoferrin”. 《FEBS Letters》 422 (2): 205–8. doi:10.1016/S0014-5793(98)00002-7. PMID 9490007. S2CID 25875928.
Andrés MT, Fierro JF (October 2010). “Antimicrobial mechanism of action of transferrins: selective inhibition of H+-ATPase”. 《Antimicrobial Agents and Chemotherapy》 54 (10): 4335–42. doi:10.1128/AAC.01620-09. PMC 2944611. PMID 20625147.
van der Strate BW, Beljaars L, Molema G, Harmsen MC, Meijer DK (December 2001). “Antiviral activities of lactoferrin”. 《Antiviral Research》 52 (3): 225–239. CiteSeerX 10.1.1.104.745. doi:10.1016/S0166-3542(01)00195-4. PMID 11675140.
Fujihara T, Hayashi K (1995). “Lactoferrin inhibits herpes simplex virus type-1 (HSV-1) infection to mouse cornea”. 《Archives of Virology》 140 (8): 1469–1472. doi:10.1007/BF01322673. PMID 7661698. S2CID 4396295.
Giansanti F, Rossi P, Massucci MT, Botti D, Antonini G, Valenti P, Seganti L (2002). “Antiviral activity of ovotransferrin discloses an evolutionary strategy for the defensive activities of lactoferrin”. 《Biochemistry and Cell Biology = Biochimie et Biologie Cellulaire》 80 (1): 125–130. doi:10.1139/o01-208. PMID 11908636.
Krzyzowska M, Chodkowski M, Janicka M, Dmowska D, Tomaszewska E, Ranoszek-Soliwoda K, 외. (January 2022). “Lactoferrin-Functionalized Noble Metal Nanoparticles as New Antivirals for HSV-2 Infection”. 《Microorganisms》 10 (1): 110. doi:10.3390/microorganisms10010110. PMC 8780146. PMID 35056558.
Harmsen MC, Swart PJ, de Béthune MP, Pauwels R, De Clercq E, The TH, Meijer DK (August 1995). “Antiviral effects of plasma and milk proteins: lactoferrin shows potent activity against both human immunodeficiency virus and human cytomegalovirus replication in vitro”. 《The Journal of Infectious Diseases》 172 (2): 380–388. doi:10.1093/infdis/172.2.380. PMID 7622881.
Puddu P, Borghi P, Gessani S, Valenti P, Belardelli F, Seganti L (September 1998). “Antiviral effect of bovine lactoferrin saturated with metal ions on early steps of human immunodeficiency virus type 1 infection”. 《The International Journal of Biochemistry & Cell Biology》 30 (9): 1055–1062. doi:10.1016/S1357-2725(98)00066-1. PMID 9785469.
Azzam HS, Goertz C, Fritts M, Jonas WB (February 2007). “Natural products and chronic hepatitis C virus”. 《Liver International》 27 (1): 17–25. doi:10.1111/j.1478-3231.2006.01408.x. PMID 17241377. S2CID 7732075.
Nozaki A, Ikeda M, Naganuma A, Nakamura T, Inudoh M, Tanaka K, Kato N (March 2003). “Identification of a lactoferrin-derived peptide possessing binding activity to hepatitis C virus E2 envelope protein”. 《The Journal of Biological Chemistry》 278 (12): 10162–10173. doi:10.1074/jbc.M207879200. PMID 12522210.
Arnold D, Di Biase AM, Marchetti M, Pietrantoni A, Valenti P, Seganti L, Superti F (February 2002). “Antiadenovirus activity of milk proteins: lactoferrin prevents viral infection”. 《Antiviral Research》 53 (2): 153–158. doi:10.1016/S0166-3542(01)00197-8. PMID 11750941.
Carvalho CA, Sousa IP, Silva JL, Oliveira AC, Gonçalves RB, Gomes AM (March 2014). “Inhibition of Mayaro virus infection by bovine lactoferrin”. 《Virology》. 452-453: 297–302. doi:10.1016/j.virol.2014.01.022. PMID 24606707.
Chang R, Ng TB, Sun WZ (September 2020). “Lactoferrin as potential preventative and adjunct treatment for COVID-19”. 《International Journal of Antimicrobial Agents》 56 (3): 106118. doi:10.1016/j.ijantimicag.2020.106118. PMC 7390755. PMID 32738305.
Wang Y, Wang P, Wang H, Luo Y, Wan L, Jiang M, Chu Y (December 2020). “Lactoferrin for the treatment of COVID-19 (Review)”. 《Experimental and Therapeutic Medicine》 20 (6): 272. doi:10.3892/etm.2020.9402. PMC 7664603. PMID 33199997.
Mirabelli C, Wotring JW, Zhang CJ, McCarty SM, Fursmidt R, Pretto CD, 외. (September 2021). “Morphological cell profiling of SARS-CoV-2 infection identifies drug repurposing candidates for COVID-19”. 《Proceedings of the National Academy of Sciences of the United States of America》 118 (36). doi:10.1073/pnas.2105815118. PMC 8433531. PMID 34413211.
Rosa L, Tripepi G, Naldi E, Aimati M, Santangeli S, Venditto F, 외. (September 2021). “Ambulatory COVID-19 Patients Treated with Lactoferrin as a Supplementary Antiviral Agent: A Preliminary Study”. 《Journal of Clinical Medicine》 10 (18): 4276. doi:10.3390/jcm10184276. PMC 8469309. PMID 34575388.
Reghunathan R, Jayapal M, Hsu LY, Chng HH, Tai D, Leung BP, Melendez AJ (January 2005). “Expression profile of immune response genes in patients with Severe Acute Respiratory Syndrome”. 《BMC Immunology》 6: 2. doi:10.1186/1471-2172-6-2. PMC 546205. PMID 15655079.
Wakabayashi H, Uchida K, Yamauchi K, Teraguchi S, Hayasawa H, Yamaguchi H (October 2000). “Lactoferrin given in food facilitates dermatophytosis cure in guinea pig models”. 《The Journal of Antimicrobial Chemotherapy》 46 (4): 595–602. doi:10.1093/jac/46.4.595. PMID 11020258.
Lupetti A, Paulusma-Annema A, Welling MM, Dogterom-Ballering H, Brouwer CP, Senesi S, Van Dissel JT, Nibbering PH (January 2003). “Synergistic activity of the N-terminal peptide of human lactoferrin and fluconazole against Candida species”. 《Antimicrobial Agents and Chemotherapy》 47 (1): 262–7. doi:10.1128/AAC.47.1.262-267.2003. PMC 149030. PMID 12499200.
Viejo-Díaz M, Andrés MT, Fierro JF (April 2004). “Modulation of in vitro fungicidal activity of human lactoferrin against Candida albicans by extracellular cation concentration and target cell metabolic activity”. 《Antimicrobial Agents and Chemotherapy》 48 (4): 1242–8. doi:10.1128/AAC.48.4.1242-1248.2004. PMC 375254. PMID 15047526.
Takakura N, Wakabayashi H, Ishibashi H, Teraguchi S, Tamura Y, Yamaguchi H, Abe S (August 2003). “Oral lactoferrin treatment of experimental oral candidiasis in mice”. 《Antimicrobial Agents and Chemotherapy》 47 (8): 2619–23. doi:10.1128/AAC.47.8.2619-2623.2003. PMC 166093. PMID 12878528.
Masci JR (October 2000). “Complete response of severe, refractory oral candidiasis to mouthwash containing lactoferrin and lysozyme”. 《AIDS》 14 (15): 2403–4. doi:10.1097/00002030-200010200-00023. PMID 11089630.
Kuipers ME, de Vries HG, Eikelboom MC, Meijer DK, Swart PJ (November 1999). “Synergistic fungistatic effects of lactoferrin in combination with antifungal drugs against clinical Candida isolates”. 《Antimicrobial Agents and Chemotherapy》 43 (11): 2635–41. doi:10.1128/AAC.43.11.2635. PMC 89536. PMID 10543740.
Andrés MT, Viejo-Díaz M, Fierro JF (November 2008). “Human lactoferrin induces apoptosis-like cell death in Candida albicans: critical role of K+-channel-mediated K+ efflux”. 《Antimicrobial Agents and Chemotherapy》 52 (11): 4081–8. doi:10.1128/AAC.01597-07. PMC 2573133. PMID 18710913.
Tsuda H, Sekine K, Fujita K, Ligo M (2002). “Cancer prevention by bovine lactoferrin and underlying mechanisms--a review of experimental and clinical studies”. 《Biochemistry and Cell Biology》 80 (1): 131–6. doi:10.1139/o01-239. PMID 11908637.
Chandra Mohan KV, Kumaraguruparan R, Prathiba D, Nagini S (September 2006). “Modulation of xenobiotic-metabolizing enzymes and redox status during chemoprevention of hamster buccal carcinogenesis by bovine lactoferrin”. 《Nutrition》 22 (9): 940–6. doi:10.1016/j.nut.2006.05.017. PMID 16928475.
McCormick JJ, Larson LJ, Rich MA (October 1974). “RNase inhibition of reverse transcriptase activity in human milk”. 《Nature》 251 (5477): 737–40. Bibcode:1974Natur.251..737M. doi:10.1038/251737a0. PMID 4139659. S2CID 4160337.
Das MR, Padhy LC, Koshy R, Sirsat SM, Rich MA (August 1976). “Human milk samples from different ethnic groups contain RNase that inhibits, and plasma membrane that stimulates, reverse transcription”. 《Nature》 262 (5571): 802–5. Bibcode:1976Natur.262..802D. doi:10.1038/262802a0. PMID 60710. S2CID 4216981.
Liao Y, Lopez V, Shafizadeh TB, Halsted CH, Lönnerdal B (November 2007). “Cloning of a pig homologue of the human lactoferrin receptor: expression and localization during intestinal maturation in piglets”. 《Comparative Biochemistry and Physiology. Part A, Molecular & Integrative Physiology》 148 (3): 584–90. doi:10.1016/j.cbpa.2007.08.001. PMC 2265088. PMID 17766154.
Rawat P, Kumar S, Sheokand N, Raje CI, Raje M (June 2012). “The multifunctional glycolytic protein glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is a novel macrophage lactoferrin receptor”. 《Biochemistry and Cell Biology》 90 (3): 329–38. doi:10.1139/o11-058. PMID 22292499.
Bharadwaj S, Naidu AG, Betageri GV, Prasadarao NV, Naidu AS (September 2009). “Milk ribonuclease-enriched lactoferrin induces positive effects on bone turnover markers in postmenopausal women”. 《Osteoporosis International》 20 (9): 1603–11. doi:10.1007/s00198-009-0839-8. PMID 19172341. S2CID 10711802.
Bharadwaj S, Naidu TA, Betageri GV, Prasadarao NV, Naidu AS (November 2010). “Inflammatory responses improve with milk ribonuclease-enriched lactoferrin supplementation in postmenopausal women”. 《Inflammation Research》 59 (11): 971–8. doi:10.1007/s00011-010-0211-7. PMID 20473630. S2CID 3180066.
Guo, Hui Yuan; Jiang, Lu; Ibrahim, Salam A.; Zhang, Lian; Zhang, Hao; Zhang, Ming; Ren, Fa Zheng (2009년 5월). “Orally administered lactoferrin preserves bone mass and microarchitecture in ovariectomized rats”. 《The Journal of Nutrition》 139 (5): 958–964. doi:10.3945/jn.108.100586. ISSN 1541-6100. PMID 19321577.
Rosenmund A, Kuyas C, Haeberli A (November 1986). “Oxidative radioiodination damage to human lactoferrin”. 《The Biochemical Journal》 240 (1): 239–45. doi:10.1042/bj2400239. PMC 1147399. PMID 3827843.
Ohashi Y, Ishida R, Kojima T, Goto E, Matsumoto Y, Watanabe K, Ishida N, Nakata K, Takeuchi T, Tsubota K (August 2003). “Abnormal protein profiles in tears with dry eye syndrome”. 《American Journal of Ophthalmology》 136 (2): 291–9. doi:10.1016/S0002-9394(03)00203-4. PMID 12888052.
Karns K, Herr AE (November 2011). “Human tear protein analysis enabled by an alkaline microfluidic homogeneous immunoassay”. 《Analytical Chemistry》 83 (21): 8115–22. doi:10.1021/ac202061v. PMID 21910436.
Lamb, C. A.; Mansfield, J. C. (2011년 1월 1일). “Measurement of faecal calprotectin and lactoferrin in inflammatory bowel disease”. 《Frontline Gastroenterology》 (영어) 2 (1): 13–18. doi:10.1136/fg.2010.001362. ISSN 2041-4137. PMID 23904968.
Kane, Sunanda V.; Sandborn, William J.; Rufo, Paul A.; Zholudev, Anna; Boone, James; Lyerly, David; Camilleri, Michael; Hanauer, Stephen B. (2003). “Fecal lactoferrin is a sensitive and specific marker in identifying intestinal inflammation”. 《The American Journal of Gastroenterology》 98 (6): 1309–1314. doi:10.1111/j.1572-0241.2003.07458.x. ISSN 0002-9270. PMID 12818275.
Zhou, Xing-lu; Xu, Wen; Tang, Xiao-xiao; Luo, Lai-sheng; Tu, Jiang-feng; Zhang, Chen-jing; Xu, Xiang; Wu, Qin-dong; Pan, Wen-sheng (2014년 7월 7일). “Fecal lactoferrin in discriminating inflammatory bowel disease from Irritable bowel syndrome: a diagnostic meta-analysis”. 《BMC Gastroenterology》 14 (1): 121. doi:10.1186/1471-230X-14-121. ISSN 1471-230X. PMC 4105129. PMID 25002150. CS1 관리 - PMC 형식 (링크)
Moskwa P, Lorentzen D, Excoffon KJ, Zabner J, McCray PB, Nauseef WM, Dupuy C, Bánfi B (January 2007). “A novel host defense system of airways is defective in cystic fibrosis”. 《American Journal of Respiratory and Critical Care Medicine》 175 (2): 174–83. doi:10.1164/rccm.200607-1029OC. PMC 2720149. PMID 17082494.
Singh PK, Schaefer AL, Parsek MR, Moninger TO, Welsh MJ, Greenberg EP (October 2000). “Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms”. 《Nature》 407 (6805): 762–4. Bibcode:2000Natur.407..762S. doi:10.1038/35037627. PMID 11048725. S2CID 4372096.
Singh PK, Parsek MR, Greenberg EP, Welsh MJ (May 2002). “A component of innate immunity prevents bacterial biofilm development”. 《Nature》 417 (6888): 552–5. Bibcode:2002Natur.417..552S. doi:10.1038/417552a. PMID 12037568. S2CID 4423528.
Rogan MP, Taggart CC, Greene CM, Murphy PG, O'Neill SJ, McElvaney NG (October 2004). “Loss of microbicidal activity and increased formation of biofilm due to decreased lactoferrin activity in patients with cystic fibrosis”. 《The Journal of Infectious Diseases》 190 (7): 1245–53. doi:10.1086/423821. PMID 15346334.
Andrés MT, Viejo-Diaz M, Pérez F, Fierro JF (April 2005). “Antibiotic tolerance induced by lactoferrin in clinical Pseudomonas aeruginosa isolates from cystic fibrosis patients”. 《Antimicrobial Agents and Chemotherapy》 49 (4): 1613–6. doi:10.1128/aac.49.4.1613-1616.2005. PMC 1068597. PMID 15793153.
Rogan MP, Geraghty P, Greene CM, O'Neill SJ, Taggart CC, McElvaney NG (February 2006). “Antimicrobial proteins and polypeptides in pulmonary innate defence”. 《Respiratory Research》 7 (1): 29. doi:10.1186/1465-9921-7-29. PMC 1386663. PMID 16503962.
Pammi M, Suresh G (March 2020). “Enteral lactoferrin supplementation for prevention of sepsis and necrotizing enterocolitis in preterm infants”. 《The Cochrane Database of Systematic Reviews》 3: CD007137. doi:10.1002/14651858.CD007137.pub6. PMC 7106972. PMID 32232984.
Xavier PL, Chaudhari K, Verma PK, Pal SK, Pradeep T (December 2010). “Luminescent quantum clusters of gold in transferrin family protein, lactoferrin exhibiting FRET” (PDF). 《Nanoscale》 2 (12): 2769–76. Bibcode:2010Nanos...2.2769X. doi:10.1039/C0NR00377H. PMID 20882247.

pubmed.ncbi.nlm.nih.gov

Kang JF, Li XL, Zhou RY, Li LH, Feng FJ, Guo XL (June 2008). “Bioinformatics analysis of lactoferrin gene for several species”. 《Biochemical Genetics》 46 (5–6): 312–22. doi:10.1007/s10528-008-9147-9. PMID 18228129. S2CID 952135.
Ward, P. P.; Mendoza-Meneses, M.; Mulac-Jericevic, B.; Cunningham, G. A.; Saucedo-Cardenas, O.; Teng, C. T.; Conneely, O. M. (1999년 4월). “Restricted spatiotemporal expression of lactoferrin during murine embryonic development”. 《Endocrinology》 140 (4): 1852–1860. doi:10.1210/endo.140.4.6671. ISSN 0013-7227. PMID 10098524.
Iyer, S.; Lönnerdal, B. (1993년 4월). “Lactoferrin, lactoferrin receptors and iron metabolism”. 《European Journal of Clinical Nutrition》 47 (4): 232–241. ISSN 0954-3007. PMID 8491159.
Teng, Christina T. (2002). “Lactoferrin gene expression and regulation: an overview”. 《Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire》 80 (1): 7–16. doi:10.1139/o01-215. ISSN 0829-8211. PMID 11908645.
Guo, Hui Yuan; Jiang, Lu; Ibrahim, Salam A.; Zhang, Lian; Zhang, Hao; Zhang, Ming; Ren, Fa Zheng (2009년 5월). “Orally administered lactoferrin preserves bone mass and microarchitecture in ovariectomized rats”. 《The Journal of Nutrition》 139 (5): 958–964. doi:10.3945/jn.108.100586. ISSN 1541-6100. PMID 19321577.
Kane, Sunanda V.; Sandborn, William J.; Rufo, Paul A.; Zholudev, Anna; Boone, James; Lyerly, David; Camilleri, Michael; Hanauer, Stephen B. (2003). “Fecal lactoferrin is a sensitive and specific marker in identifying intestinal inflammation”. 《The American Journal of Gastroenterology》 98 (6): 1309–1314. doi:10.1111/j.1572-0241.2003.07458.x. ISSN 0002-9270. PMID 12818275.

nii.ac.jp

ci.nii.ac.jp

近藤一郎; 小林哲夫・若林裕之・山内恒治・岩附慧二・吉江弘正 (2008). “歯周炎患者におけるウシラクトフェリン経口投与の影響”. 《日本歯科保存学雑誌》 (特定非営利活動法人日本歯科保存学会) 51 (3): 281–291. ISSN 0387-2343. NAID 110007151243.

psu.edu

citeseerx.ist.psu.edu

van der Strate BW, Beljaars L, Molema G, Harmsen MC, Meijer DK (December 2001). “Antiviral activities of lactoferrin”. 《Antiviral Research》 52 (3): 225–239. CiteSeerX 10.1.1.104.745. doi:10.1016/S0166-3542(01)00195-4. PMID 11675140.

rupress.org

Masson, P. L.; Heremans, J. F.; Schonne, E. (1969년 9월 1일). “Lactoferrin, an iron-binding protein in neutrophilic leukocytes”. 《The Journal of Experimental Medicine》 130 (3): 643–658. doi:10.1084/jem.130.3.643. ISSN 0022-1007. PMC 2138704. PMID 4979954.

sciencedirect.com

Sanchez, Lourdes; Lujan, Luis; Oria, Rosa; Castillo, Helena; Perez, Dolores; Ena, Jose Manuel; Calvo, Miguel (1992년 5월 1일). “Synthesis of Lactoferrin and Transport of Transferrin in the Lactating Mammary Gland of Sheep”. 《Journal of Dairy Science》 (영어) 75 (5): 1257–1262. doi:10.3168/jds.S0022-0302(92)77875-8. ISSN 0022-0302.
Manzoni, Paolo; Meyer, Michael; Stolfi, Ilaria; Rinaldi, Matteo; Cattani, Silvia; Pugni, Lorenza; Romeo, Mario Giovanni; Messner, Hubert; Decembrino, Lidia (2014년 3월 1일). “Bovine lactoferrin supplementation for prevention of necrotizing enterocolitis in very-low-birth-weight neonates: a randomized clinical trial”. 《Early Human Development》 (영어) 90: S60–S65. doi:10.1016/S0378-3782(14)70020-9. ISSN 0378-3782.

semanticscholar.org

api.semanticscholar.org

Ali AS, Hasan SS, Kow CS, Merchant HA (October 2021). “Lactoferrin reduces the risk of respiratory tract infections: A meta-analysis of randomized controlled trials”. 《Clinical Nutrition ESPEN》 45: 26–32. doi:10.1016/j.clnesp.2021.08.019. PMID 34620326. S2CID 238475090.
Kang JF, Li XL, Zhou RY, Li LH, Feng FJ, Guo XL (June 2008). “Bioinformatics analysis of lactoferrin gene for several species”. 《Biochemical Genetics》 46 (5–6): 312–22. doi:10.1007/s10528-008-9147-9. PMID 18228129. S2CID 952135.
Baker EN, Baker HM (November 2005). “Molecular structure, binding properties and dynamics of lactoferrin”. 《Cellular and Molecular Life Sciences》 62 (22): 2531–9. doi:10.1007/s00018-005-5368-9. PMID 16261257. S2CID 218464085.
Xanthou M (1998). “Immune protection of human milk”. 《Biology of the Neonate》 74 (2): 121–33. doi:10.1159/000014018. PMID 9691154. S2CID 46828227.
Odell EW, Sarra R, Foxworthy M, Chapple DS, Evans RW (March 1996). “Antibacterial activity of peptides homologous to a loop region in human lactoferrin”. 《FEBS Letters》 382 (1–2): 175–8. doi:10.1016/0014-5793(96)00168-8. PMID 8612745. S2CID 30937106.
Sojar HT, Hamada N, Genco RJ (January 1998). “Structures involved in the interaction of Porphyromonas gingivalis fimbriae and human lactoferrin”. 《FEBS Letters》 422 (2): 205–8. doi:10.1016/S0014-5793(98)00002-7. PMID 9490007. S2CID 25875928.
Fujihara T, Hayashi K (1995). “Lactoferrin inhibits herpes simplex virus type-1 (HSV-1) infection to mouse cornea”. 《Archives of Virology》 140 (8): 1469–1472. doi:10.1007/BF01322673. PMID 7661698. S2CID 4396295.
Azzam HS, Goertz C, Fritts M, Jonas WB (February 2007). “Natural products and chronic hepatitis C virus”. 《Liver International》 27 (1): 17–25. doi:10.1111/j.1478-3231.2006.01408.x. PMID 17241377. S2CID 7732075.
McCormick JJ, Larson LJ, Rich MA (October 1974). “RNase inhibition of reverse transcriptase activity in human milk”. 《Nature》 251 (5477): 737–40. Bibcode:1974Natur.251..737M. doi:10.1038/251737a0. PMID 4139659. S2CID 4160337.
Das MR, Padhy LC, Koshy R, Sirsat SM, Rich MA (August 1976). “Human milk samples from different ethnic groups contain RNase that inhibits, and plasma membrane that stimulates, reverse transcription”. 《Nature》 262 (5571): 802–5. Bibcode:1976Natur.262..802D. doi:10.1038/262802a0. PMID 60710. S2CID 4216981.
Bharadwaj S, Naidu AG, Betageri GV, Prasadarao NV, Naidu AS (September 2009). “Milk ribonuclease-enriched lactoferrin induces positive effects on bone turnover markers in postmenopausal women”. 《Osteoporosis International》 20 (9): 1603–11. doi:10.1007/s00198-009-0839-8. PMID 19172341. S2CID 10711802.
Bharadwaj S, Naidu TA, Betageri GV, Prasadarao NV, Naidu AS (November 2010). “Inflammatory responses improve with milk ribonuclease-enriched lactoferrin supplementation in postmenopausal women”. 《Inflammation Research》 59 (11): 971–8. doi:10.1007/s00011-010-0211-7. PMID 20473630. S2CID 3180066.
Singh PK, Schaefer AL, Parsek MR, Moninger TO, Welsh MJ, Greenberg EP (October 2000). “Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms”. 《Nature》 407 (6805): 762–4. Bibcode:2000Natur.407..762S. doi:10.1038/35037627. PMID 11048725. S2CID 4372096.
Singh PK, Parsek MR, Greenberg EP, Welsh MJ (May 2002). “A component of innate immunity prevents bacterial biofilm development”. 《Nature》 417 (6888): 552–5. Bibcode:2002Natur.417..552S. doi:10.1038/417552a. PMID 12037568. S2CID 4423528.

vri.cz

Adlerova L, Bartoskova A, Faldyna M (2008). “Lactoferrin: a review” (PDF). 《Veterinarni Medicina》 53 (9): 457. doi:10.17221/1978-VETMED. 2020년 1월 9일에 원본 문서 (PDF)에서 보존된 문서. 2022년 7월 16일에 확인함.

web.archive.org

Adlerova L, Bartoskova A, Faldyna M (2008). “Lactoferrin: a review” (PDF). 《Veterinarni Medicina》 53 (9): 457. doi:10.17221/1978-VETMED. 2020년 1월 9일에 원본 문서 (PDF)에서 보존된 문서. 2022년 7월 16일에 확인함.
“Public summary of positive opinion for orphan designation of hypothiocyanite/lactoferrin for the treatment of cystic fibrosis” (PDF). 《Pre-authorisation Evaluation of Medicines for Human Use》. European Medicines Agency. 2009년 9월 7일. 2010년 5월 30일에 원본 문서 (PDF)에서 보존된 문서. 2010년 1월 23일에 확인함.
“Meveol: orphan drug status granted by the FDA for the treatment of cystic fibrosis”. United States Food and Drug Administration. 2009년 11월 5일. 2009년 12월 24일에 원본 문서에서 보존된 문서. 2010년 1월 23일에 확인함.

wiley.com

doi.wiley.com

Fillebeen, Carine; Dehouck, Bénédicte; Benaïssa, Monique; Dhennin-Duthille, Isabelle; Cecchelli, Roméo; Pierce, Annick (2002년 1월 18일). “Tumor Necrosis Factor-α Increases Lactoferrin Transcytosis Through the Blood-Brain Barrier”. 《Journal of Neurochemistry》 (영어) 73 (6): 2491–2500. doi:10.1046/j.1471-4159.1999.0732491.x.

onlinelibrary.wiley.com

Cui, Shixiu; Lv, Xueqin; Sun, Guoyun; Wu, Wenyang; Xu, Hong; Li, Yuelong; Liu, Yanfeng; Li, Jianghua; Du, Guocheng (2022년 3월). “Recent advances and prospects in purification and heterologous expression of lactoferrin”. 《Food Bioengineering》 (영어) 1 (1): 58–67. doi:10.1002/fbe2.12003. ISSN 2770-2081.

worldcat.org

Masson, P. L.; Heremans, J. F.; Schonne, E. (1969년 9월 1일). “Lactoferrin, an iron-binding protein in neutrophilic leukocytes”. 《The Journal of Experimental Medicine》 130 (3): 643–658. doi:10.1084/jem.130.3.643. ISSN 0022-1007. PMC 2138704. PMID 4979954.
Elzoghby, Ahmed O.; Abdelmoneem, Mona A.; Hassanin, Islam A.; Abd Elwakil, Mahmoud M.; Elnaggar, Manar A.; Mokhtar, Sarah; Fang, Jia-You; Elkhodairy, Kadria A. (2020년 12월). “Lactoferrin, a multi-functional glycoprotein: Active therapeutic, drug nanocarrier & targeting ligand”. 《Biomaterials》 263: 120355. doi:10.1016/j.biomaterials.2020.120355. ISSN 0142-9612. PMC 7480805. PMID 32932142.
Giansanti, Francesco; Panella, Gloria; Leboffe, Loris; Antonini, Giovanni (2016년 9월 27일). “Lactoferrin from Milk: Nutraceutical and Pharmacological Properties”. 《Pharmaceuticals》 9 (4): 61. doi:10.3390/ph9040061. ISSN 1424-8247. PMC 5198036. PMID 27690059.
Sinha, Mau; Kaushik, Sanket; Kaur, Punit; Sharma, Sujata; Singh, Tej P. (2013). “Antimicrobial Lactoferrin Peptides: The Hidden Players in the Protective Function of a Multifunctional Protein”. 《International Journal of Peptides》 2013: 390230. doi:10.1155/2013/390230. ISSN 1687-9767. PMC 3608178. PMID 23554820.
Bruni, Natascia; Capucchio, Maria Teresa; Biasibetti, Elena; Pessione, Enrica; Cirrincione, Simona; Giraudo, Leonardo; Corona, Antonio; Dosio, Franco (2016년 6월 11일). “Antimicrobial Activity of Lactoferrin-Related Peptides and Applications in Human and Veterinary Medicine”. 《Molecules》 21 (6): 752. doi:10.3390/molecules21060752. ISSN 1420-3049. PMC 6273662. PMID 27294909.
Does, Anne M. van der; Hensbergen, Paul J.; Bogaards, Sylvia J.; Cansoy, Medine; Deelder, André M.; Leeuwen, Hans C. van; Drijfhout, Jan W.; Dissel, Jaap T. van; Nibbering, Peter H. (2012년 5월 15일). “The Human Lactoferrin-Derived Peptide hLF1-11 Exerts Immunomodulatory Effects by Specific Inhibition of Myeloperoxidase Activity”. 《The Journal of Immunology》 (영어) 188 (10): 5012–5019. doi:10.4049/jimmunol.1102777. ISSN 0022-1767. PMID 22523385.
Ward, P. P.; Mendoza-Meneses, M.; Mulac-Jericevic, B.; Cunningham, G. A.; Saucedo-Cardenas, O.; Teng, C. T.; Conneely, O. M. (1999년 4월). “Restricted spatiotemporal expression of lactoferrin during murine embryonic development”. 《Endocrinology》 140 (4): 1852–1860. doi:10.1210/endo.140.4.6671. ISSN 0013-7227. PMID 10098524.
Iyer, S.; Lönnerdal, B. (1993년 4월). “Lactoferrin, lactoferrin receptors and iron metabolism”. 《European Journal of Clinical Nutrition》 47 (4): 232–241. ISSN 0954-3007. PMID 8491159.
Sanchez, Lourdes; Lujan, Luis; Oria, Rosa; Castillo, Helena; Perez, Dolores; Ena, Jose Manuel; Calvo, Miguel (1992년 5월 1일). “Synthesis of Lactoferrin and Transport of Transferrin in the Lactating Mammary Gland of Sheep”. 《Journal of Dairy Science》 (영어) 75 (5): 1257–1262. doi:10.3168/jds.S0022-0302(92)77875-8. ISSN 0022-0302.
Fillebeen, C.; Descamps, L.; Dehouck, M. P.; Fenart, L.; Benaïssa, M.; Spik, G.; Cecchelli, R.; Pierce, A. (1999년 3월 12일). “Receptor-mediated transcytosis of lactoferrin through the blood-brain barrier”. 《The Journal of Biological Chemistry》 274 (11): 7011–7017. doi:10.1074/jbc.274.11.7011. ISSN 0021-9258. PMID 10066755.
Teng, Christina T. (2002). “Lactoferrin gene expression and regulation: an overview”. 《Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire》 80 (1): 7–16. doi:10.1139/o01-215. ISSN 0829-8211. PMID 11908645.
Berlutti, Francesca; Pilloni, Andrea; Pietropaoli, Miriam; Polimeni, Antonella; Valenti, Piera (2012년 1월 27일). “Lactoferrin and oral diseases: current status and perspective in periodontitis”. 《Annali di Stomatologia》 2 (3-4): 10–18. ISSN 1824-0852. PMC 3314318. PMID 22545184.
Guo, Hui Yuan; Jiang, Lu; Ibrahim, Salam A.; Zhang, Lian; Zhang, Hao; Zhang, Ming; Ren, Fa Zheng (2009년 5월). “Orally administered lactoferrin preserves bone mass and microarchitecture in ovariectomized rats”. 《The Journal of Nutrition》 139 (5): 958–964. doi:10.3945/jn.108.100586. ISSN 1541-6100. PMID 19321577.
Lamb, C. A.; Mansfield, J. C. (2011년 1월 1일). “Measurement of faecal calprotectin and lactoferrin in inflammatory bowel disease”. 《Frontline Gastroenterology》 (영어) 2 (1): 13–18. doi:10.1136/fg.2010.001362. ISSN 2041-4137. PMID 23904968.
Kane, Sunanda V.; Sandborn, William J.; Rufo, Paul A.; Zholudev, Anna; Boone, James; Lyerly, David; Camilleri, Michael; Hanauer, Stephen B. (2003). “Fecal lactoferrin is a sensitive and specific marker in identifying intestinal inflammation”. 《The American Journal of Gastroenterology》 98 (6): 1309–1314. doi:10.1111/j.1572-0241.2003.07458.x. ISSN 0002-9270. PMID 12818275.
Walker, Thomas R.; Land, Michelle L.; Kartashov, Alex; Saslowsky, Tracee M.; Lyerly, David M.; Boone, James H.; Rufo, Paul A. (2007년 4월). “Fecal Lactoferrin Is a Sensitive and Specific Marker of Disease Activity in Children and Young Adults With Inflammatory Bowel Disease”. 《Journal of Pediatric Gastroenterology and Nutrition》 (미국 영어) 44 (4): 414–422. doi:10.1097/MPG.0b013e3180308d8e. ISSN 0277-2116.
Zhou, Xing-lu; Xu, Wen; Tang, Xiao-xiao; Luo, Lai-sheng; Tu, Jiang-feng; Zhang, Chen-jing; Xu, Xiang; Wu, Qin-dong; Pan, Wen-sheng (2014년 7월 7일). “Fecal lactoferrin in discriminating inflammatory bowel disease from Irritable bowel syndrome: a diagnostic meta-analysis”. 《BMC Gastroenterology》 14 (1): 121. doi:10.1186/1471-230X-14-121. ISSN 1471-230X. PMC 4105129. PMID 25002150. CS1 관리 - PMC 형식 (링크)
Manzoni, Paolo; Meyer, Michael; Stolfi, Ilaria; Rinaldi, Matteo; Cattani, Silvia; Pugni, Lorenza; Romeo, Mario Giovanni; Messner, Hubert; Decembrino, Lidia (2014년 3월 1일). “Bovine lactoferrin supplementation for prevention of necrotizing enterocolitis in very-low-birth-weight neonates: a randomized clinical trial”. 《Early Human Development》 (영어) 90: S60–S65. doi:10.1016/S0378-3782(14)70020-9. ISSN 0378-3782.
近藤一郎; 小林哲夫・若林裕之・山内恒治・岩附慧二・吉江弘正 (2008). “歯周炎患者におけるウシラクトフェリン経口投与の影響”. 《日本歯科保存学雑誌》 (特定非営利活動法人日本歯科保存学会) 51 (3): 281–291. ISSN 0387-2343. NAID 110007151243.
Cui, Shixiu; Lv, Xueqin; Sun, Guoyun; Wu, Wenyang; Xu, Hong; Li, Yuelong; Liu, Yanfeng; Li, Jianghua; Du, Guocheng (2022년 3월). “Recent advances and prospects in purification and heterologous expression of lactoferrin”. 《Food Bioengineering》 (영어) 1 (1): 58–67. doi:10.1002/fbe2.12003. ISSN 2770-2081.
Zhang, Guomei (2013년 6월 1일). “Functional gold nanoparticles for sensing applications”. 《Nanotechnology Reviews》 (영어) 2 (3): 269–288. doi:10.1515/ntrev-2012-0088. ISSN 2191-9097.